Serbia receives 1 million doses of China’s Sinopharm vaccine Description video: For more:\nhttps://www.cgtn.com/video\n\nSerbia received one million doses of the coronavirus vaccine developed by China’s Sinopharm, a Beijing-based pharmaceutical company, on Saturday. The Balkan country has signed deals with several Chinese […]
Serbia receives 1 million doses of China’s Sinopharm vaccine
For more:\nhttps://www.cgtn.com/video\n\nSerbia received one million doses of the coronavirus vaccine developed by China’s Sinopharm, a Beijing-based pharmaceutical company, on Saturday. The Balkan country has signed deals with several Chinese drugmakers for up to eight million doses to inoculate its four million people. Serbia says it has so far vaccinated more than 9,000 people in high-risk groups, including the elderly and healthcare workers.\n\nSubscribe to us on YouTube: https://goo.gl/lP12gA\nDownload our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh\u0026ls=1\u0026mt=8\nDownload our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
Chinese Sinopharm Vaccine Received Over A Million
Late Wednesday, the company said about a million people had received injections of an experimental coronavirus vaccine developed by the China National Pharmaceutical Group (Sinopharm) as part of its emergency response program..
In July, China launched an emergency vaccine program, which currently includes three vaccine candidates for specific categories of citizens. At the same time, clinical studies designed to prove their safety and effectiveness have not yet been completed..
Sinopharm reports with reference to the head of the company Liu Jingzhen (Liu Jingzhen) In an article posted on WeChat, no serious adverse reactions were found in those who received the emergency vaccine.
Two vaccine candidates developed by Sinopharm subsidiary China National Biotec Group (CNBG) and a third vaccine developed by Sinovac Biotech were used for the emergency program.
While it is unclear which vaccine Liu mentioned, Sinopharm was not available for comment.
Clinical registration data has shown that two injections of Sinopharm vaccine, which use an inactivated virus unable to replicate in human cells, will be required to trigger immune responses..
Experimental vaccines are in the third phase of clinical trials abroad, in which nearly 60 thousand have participated people, and blood samples of more than 40 thousand participants were taken 14 days after they received the second dose, according to the article.
It is also claimed that among construction project staff, diplomats and students who went abroad after the Sinopharm vaccination, no one contracted the coronavirus..
At the same time, experts warn against using data solely from the emergency use program to determine the effectiveness of a vaccine – without comparable results obtained in a control group that meets the standard of clinical trials..